文献速递神经肿瘤小儿神经外科与脑积水

高级别胶质瘤相关脑积水的脑脊液分流:危险因素、指征与有效性系统综述与荟萃分析

Risk Factors, Indications, and Effectiveness of Cerebrospinal Fluid Diversion in Patients With High-Grade Glioma-Associated Hydrocephalus: A Systematic Review and Meta-Analysis.
PubMed 文献 · Neurosurgery · 2025-06-25

该系统综述与荟萃分析纳入15项研究共4901例高级别胶质瘤患者,其中333例合并脑积水,汇总脑积水比例为8%(95%CI 3.63-16.3)。

要点

  • 高级别胶质瘤患者脑积水汇总比例为8%。
  • 脑脊液分流后79%患者症状改善,KPS平均提高15.04分。
  • 分流后中位生存期4.7个月,并发症率28%。

核心结论

  • 成人高级别胶质瘤相关脑积水行脑脊液分流可显著改善KPS评分和症状。
  • 若患者优先考虑功能与症状改善,可推荐脑脊液分流。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、SCOPUS、CINAHL、Cochrane和Embase数据库。
  • 共纳入15项研究,4901例高级别胶质瘤患者,其中333例合并脑积水。

主要发现

  • 高级别胶质瘤患者中脑积水汇总比例为8%(95%CI 3.63-16.3)。
  • 248例报告症状的患者中,认知下降110例(44%)、步态障碍87例(35%)、头痛79例(32%)、意识恶化48例(19%)。
  • 非加权中位分流后生存期为4.7个月(范围2.7-7个月),并发症率28%(67/243)。

关键数值与推荐

  • 脑积水汇总比例8%(95%CI 3.63-16.3)。
  • 中位分流后生存期4.7个月(范围2.7-7个月)。
  • 并发症率28%(67/243)。

临床怎么用

  • 对高级别胶质瘤相关脑积水患者,若以功能和症状改善为目标,可考虑脑脊液分流。
  • 分流后需关注并发症,报道并发症率为28%。

局限性

  • 纳入研究间可能存在异质性,部分结局数据有限。
  • 生存期为非加权中位数,且范围较宽。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The role of cerebrospinal fluid (CSF) diversion in patients with high-grade glioma (HGG)-associated hydrocephalus is debated. This systematic review and meta-analysis summarizes the risk factors, indications, and effectiveness of CSF diversion in patients with HGG-associated hydrocephalus, with the goal of evaluating patient survival, functional improvement, and symptomatic improvement after CSF diversion. METHODS: PubMed, SCOPUS, CINAHL, Cochrane, and Embase databases were queried according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines to identify studies describing adult HGG patients with hydrocephalus who underwent CSF diversion. Primary outcomes included symptomatic improvement, survival after CSF diversion, and Karnofsky Performance Status (KPS) before and after CSF diversion. Secondary outcomes included risk of hydrocephalus with ventricular opening during initial tumor resection, and CSF diversion-related complications and mortality. RESULTS: A total of 15 studies yielded 4901 patients with HGG, of whom 333 suffered from HGG-associated hydrocephalus. Pooled proportion of patients with hydrocephalus among those with HGG was 8% (95% CI 3.63-16.3). Of 248 patients for which presenting symptoms of hydrocephalus were reported, the most common symptoms were cognitive decline (n = 110, 44%), gait disturbance (n = 87, 35%), headache (n = 79, 32%), and deteriorating consciousness (n = 48, 19%). After CSF diversion, 79% (95% CI 70.1-89.7, P < .01) of patients demonstrated symptomatic improvement. In studies that reported both pre- and post-shunt KPS score, there was a pooled mean increase of 15.04 points (95% CI 10.16-19.91, P < .00001) after shunting. The average, nonweighted median post-CSF diversion survival was 4.7 months (range, 2.7-7 months). The complication rate of CSF diversion was 28% (67/243) for patients in publications that reported complications. No cases of peritoneal seeding after CSF diversion were reported in the included studies. CONCLUSION: CSF diversion in adults with HGG-associated hydrocephalus led to a significant improvement in both KPS score and symptoms. If functionality and symptom improvement are patients' priorities, CSF diversion may be recommended.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Tracz JA, Saint-Germain MA, Kuo CC, et al. Risk Factors, Indications, and Effectiveness of Cerebrospinal Fluid Diversion in Patients With High-Grade Glioma-Associated Hydrocephalus: A Systematic Review and Meta-Analysis. Neurosurgery. 2025. PMID: 40558064. doi:10.1227/neu.0000000000003592

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。